A Novel Approach of Combining Methylene Blue Photodynamic Inactivation, Photobiomodulation and Oral Ingested Methylene Blue in COVID-19 Management: A Pilot Clinical Study with 12-Month Follow-Up

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 virus was first recognized in late 2019 and remains a significant threat. We therefore assessed the use of local methylene blue photodynamic viral inactivation (MB-PDI) in the oral and nasal cavities, in combination with the systemic anti-vira...

Descripción completa

Detalles Bibliográficos
Autores principales: Hepburn, Juliette, Williams-Lockhart, Susan, Bensadoun, René Jean, Hanna, Reem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686966/
https://www.ncbi.nlm.nih.gov/pubmed/36358582
http://dx.doi.org/10.3390/antiox11112211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686966/
https://www.ncbi.nlm.nih.gov/pubmed/36358582
http://dx.doi.org/10.3390/antiox11112211

Ejemplares similares